CClinicalTrials.gg
CompletedNCT03264391Updated Jan 13, 2021

Evaluation of Macular Vascular Changes in Behcet's Disease Using Optical Coherence Tomography Angiography

An observational study in Retinal Vasculitis and Behcet Syndrome, sponsored by Assiut University. Completed at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-01-13.

Sponsored by Assiut University · Observational

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
30
Ages
18 Years and older
Sex
All
01

Study summary

Behcet's disease is an important cause of retinal vasculitis and vision loss in Egypt. Fluorescein angiography is the standard method of diagnosis of retinal vasculitis. OCT angiography (OCT-A) is a recently developed method that can be used in the evaluation of retinal circulation. In this study, we will test the utility of OCT-A in diagnosis and follow up of retinal vascular changes in cases diagnosed with Behcet's disease that visit the outpatient uveitis clinic of Assiut University hospital, a major tertiary center in southern Egypt, over a one year duration. Also, correlation of OCT-A changes with visual acuity and hence prognosis will be described.

Read the detailed description

Aim of the research To describe macular retinal vascular changes in patient with retinal vasculitis secondary to Behcet's disease both qualitatively and quantitatively.

Research design Type of the study: cross sectional analytical study Study Setting: Assuit University Hospital (Ophthalmology Department)

Study subjects:

  1. Inclusion criteria:

    • Patients diagnosed with Behcet's disease with or without active uveitis
  2. Exclusion criteria:

    • Patients less than 18 years old
    • Hazy media precluding clear fundus view.
    • Patients with very poor fixation.
  3. Sample Size Calculation:

We will aim at recruiting all patients diagnosed with Behcet's disease in outpatient clinic who will meet the inclusion criteria within one year from the start of our project.

Methods Subject recruitment and obtaining consent Study subjects (Behcet's patients) will be recruited from patients attending uveitis and retina clinic of the ophthalmology Department, Faculty of Medicine, Assiut University. Written informed consent form will be obtained from each patient.

Baseline evaluation:

  1. Full ocular examination including slit lamp and dilated fundus examinations. Also, measurement of the best corrected visual acuity (BCVA) using Snellen's chart will be done.
  2. Thorough clinical history and review of other systems involvement as well as full drug history including use of topical and systemic medications.
  3. Retinal vasculitis will be diagnosed by fundus examination. Additionally, fluorescein angiography may be done according to the discretion of the investigators to confirm the diagnosis.

Optical coherence tomography angiography imaging OCT imaging will be performed after pupillary dilatation using Topcon DRI OCT Triton platform which utilizes invisible 1050 nm light and obtains images at a speed of 100,000 A scans/sec.

First, B scans of the macula will be obtained and anatomical alterations of retinal architecture will be noted. Next, OCT angiography scans in a 4.5x 4.5 mm circle centered on the fovea will be then obtained. Analysis and interpretation of the enface images of the superficial and deep retinal capillary plexus as well as choriocapillaries will be performed. Areas of capillary dropout, abnormalities of retinal capillaries and vessels such as looping, dilated segments, microaneurysms as well as FAZ area will be documented.

Research outcome measures:

A. Primary (main):

1- Qualitative description of the retinal capillary plexus changes in the macular area

B. Secondary:

  1. Quantification of the extent of macular ischemia by measuring the area of foveal avascular zone (FAZ).
  2. Correlation between extent of macular vascular changes and visual acuity

Data management and analysis:

Data collection data will be recorded in the form of excel spreadsheets Computer software SPSS and Prism graphpad Statistical tests chi square test and Pearson correlation coefficient

02

Conditions studied

  • Retinal Vasculitis
  • Behcet Syndrome

Keywords

  • OCT-A
  • Retinal vasculitis
  • Behcet's disease
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients diagnosed with Behcet's disease

Inclusion criteria

    • Patients diagnosed with Behcet's disease

Exclusion criteria

Exclusion Criteria:

    • Patients less than 18 years old

      • Hazy media precluding clear fundus view.
      • Patients with very poor fixation.
04

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
30 participants (actual)
Patient registry
No
05

What researchers measure

Primary outcomes

  1. Qualitative description of the retinal capillary plexus changes in the macular area

    Time frame: 1 year

Secondary outcomes

  1. Correlation between extent of macular vascular changes and visual acuity

    Time frame: 1 year

06

Study locations

1 site
  • Faculty of medicine
    Assiut, Egypt
07

References and documents

Publications

  • Bazvand F, Zarei M, Ebrahimiadib N, Karkhaneh R, Davoudi S, Soleimanzadeh M, Sharifian E, Roohipoor R, Modjtahedi BS. Ocular Manifestations, Conventional Fundus Fluorescein Angiographic Findings, and Relationship Between Angiographic Findings and Visual Acuity in Behcet's Disease. Semin Ophthalmol. 2017;32(6):764-771. doi: 10.1080/08820538.2016.1178310. Epub 2016 Aug 10. PubMed 27715380 ↗
  • Fingler J, Readhead C, Schwartz DM, Fraser SE. Phase-contrast OCT imaging of transverse flows in the mouse retina and choroid. Invest Ophthalmol Vis Sci. 2008 Nov;49(11):5055-9. doi: 10.1167/iovs.07-1627. Epub 2008 Jun 19. PubMed 18566457 ↗
  • Leitgeb RA, Schmetterer L, Hitzenberger CK, Fercher AF, Berisha F, Wojtkowski M, Bajraszewski T. Real-time measurement of in vitro flow by Fourier-domain color Doppler optical coherence tomography. Opt Lett. 2004 Jan 15;29(2):171-3. doi: 10.1364/ol.29.000171. PubMed 14744000 ↗

Individual participant data

Plan to share: Undecided

08

Registry details

Key details

Study ID
NCT03264391
Lead sponsor
Assiut University
Responsible party
Menatallah Saleh (Principal Investigator, Assiut University) — Principal investigator
First posted
Aug 29, 2017
Start date
Mar 1, 2018
Primary completion
Dec 30, 2019
Completion
Jan 31, 2020
Last update
Jan 13, 2021

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion